These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 6327591)
41. Effects of muramyl peptides on macrophages, monokines, and sleep. Pabst MJ; Beranova-Giorgianni S; Krueger JM Neuroimmunomodulation; 1999; 6(4):261-83. PubMed ID: 10393513 [TBL] [Abstract][Full Text] [Related]
42. [Effect of novel derivatives of muramyl dipeptide on the immune system]. Kaliuzhin OV; Fuks BB; Bovin NV; Zemliakov AE; Chirva VIa Biull Eksp Biol Med; 1994 May; 117(5):510-3. PubMed ID: 9296705 [No Abstract] [Full Text] [Related]
43. Anti-stress activity in a muramyl-dipeptide. Singh N; Jain RK; Gupta CM; Anand N Indian J Exp Biol; 1990 Jul; 28(7):686-7. PubMed ID: 2272655 [TBL] [Abstract][Full Text] [Related]
44. Comparative susceptibility of a peptidoglycan monomer from Brevibacterium divaricatum and its anhydromuramyl analogue to hydrolysis with N-acetylmuramyl-L-alanine amidase. Isolation and characterization of anhydromuramyl-peptidoglycan monomer. Tomasić J; Sesartić L; Martin SA; Valinger Z; Ladesić B J Chromatogr; 1988 May; 440():405-14. PubMed ID: 2900248 [TBL] [Abstract][Full Text] [Related]
45. Differential role of interferon-gamma in the potentiating effect of muramyl peptides for enhanced responses to lipopolysaccharide in mice: effect of cyclosporin A. Beigneux A; Huang J; Le Contel C; Heremans H; Parant MA J Interferon Cytokine Res; 1995 Apr; 15(4):359-65. PubMed ID: 7627811 [TBL] [Abstract][Full Text] [Related]
46. Specific binding of glucosaminylmuramyl peptides to histones. Golovina T; Fattakhova G; Swiderek K; Makarov E; Bovin N; Shively J; Nesmeyanov V FEBS Lett; 1999 Jul; 454(1-2):152-6. PubMed ID: 10413114 [TBL] [Abstract][Full Text] [Related]
47. Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives. Stanton JL; Watthey JW; Desai MN; Finn BM; Babiarz JE; Tomaselli HC J Med Chem; 1985 Nov; 28(11):1603-6. PubMed ID: 2999394 [TBL] [Abstract][Full Text] [Related]
48. Muroctasin. A new muramyl dipeptide derivative, MDP-Lys(L18). Arzneimittelforschung; 1988 Jul; 38(7A):951-1074. PubMed ID: 3190801 [No Abstract] [Full Text] [Related]
49. Liposome encapsulation of muramyl peptides for activation of macrophage cytotoxic properties. Nayar R; Schroit AJ; Fidler IJ Methods Enzymol; 1986; 132():594-603. PubMed ID: 3547028 [No Abstract] [Full Text] [Related]
56. Bacterial peptidoglycans as modulators of sleep. II. Effects of muramyl peptides on the structure of rabbit sleep. Krueger JM; Davenne D; Walter J; Shoham S; Kubillus SL; Rosenthal RS; Martin SA; Biemann K Brain Res; 1987 Feb; 403(2):258-66. PubMed ID: 3103866 [TBL] [Abstract][Full Text] [Related]
57. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use]. Castrillón LE Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614 [No Abstract] [Full Text] [Related]
58. Influences of the chemical structure on the activity of new inhibitory compounds of the angiotensin-converting enzyme. Siems WE; Heder G; Jentzsch KD; Burkhardt U; Johne S; Kühmstedt H; Kottke K; Wunderlich I; Oehme P Experientia; 1986 Feb; 42(2):141-4. PubMed ID: 3005025 [TBL] [Abstract][Full Text] [Related]
59. Synthesis of neo-glycosylated L-alanyl-D-isoglutamine derivatives as potential immunoadjuvants. Siedler F; Rudolph S; Musiol HJ; Moroder L Pept Res; 1992; 5(1):39-47. PubMed ID: 1623302 [TBL] [Abstract][Full Text] [Related]
60. Isolation of A58365A and A58365B, angiotensin converting enzyme inhibitors produced by Streptomyces chromofuscus. Mynderse JS; Samlaska SK; Fukuda DS; Du Bus RH; Baker PJ J Antibiot (Tokyo); 1985 Aug; 38(8):1003-7. PubMed ID: 2995292 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]